Pharmacists in Lino Lakes, MN Accepting Medicare

5 Pharmacists found. Showing 1 - 5

Dr. Erin Kraemer Suomala, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 391 Arrowhead Dr, Lino Lakes, MN 55014 Phone: 320-420-0748

Dr. Aaron B Jennissen, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1435 Sherman Lake Rd, Lino Lakes, MN 55038 Phone: 651-207-8519

Rebecca Lynn Mcneil, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 749 Apollo Dr, T-1448, Lino Lakes, MN 55014 Phone: 651-784-7618

Jenelle M Boesch, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 749 Apollo Dr, T1448, Lino Lakes, MN 55014 Phone: 651-784-7618

Virginia Mullen Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 749 Apollo Dr, Lino Lakes, MN 55014 Phone: 651-784-7618

News Archive

Enriched diet and companionship can reduce pain in mice with sickle cell disease

Researchers from the University of California, Irvine and the University of Minnesota have found that an enriched diet and companionship can reduce pain in mice with sickle cell disease by increasing serotonin.

ICN Food List for interstitial cystitis/bladder pain syndrome patients

When one cup of coffee, tea or cranberry juice can trigger days of pain and/or bladder discomfort, interstitial cystitis, overactive bladder and other urology patients often develop an unhealthy fear of food. A new iPhone and iPad application, (ICN Food List) seeks to change that by giving patients an easy to use food list and database that they can use while shopping and eating out at restaurants.

Study shows older children can benefit from treatment of eye disorder

For decades, vision specialists believed that a condition called amblyopia, or "lazy eye," must be treated before a child turns 7 to be successful. But a new study, involving Vanderbilt Children's Hospital researchers, finds it's not too late for older children.

Efalizumab effective in treatment of heavy psoriasis

A meta-analysis of four randomized Phase III placebo-controlled trials confirms that the injectable drug Efalizumab, a humanized therapeutic antibody designed to selectively and reversibly block the activation, reactivation and trafficking of T-cells that lead to the development of psoriasis, had an acceptable safety and efficacy profile in the treatment of psoriasis in heavy patients, researchers at Mount Sinai School of Medicine announced today.

Western Dental stops taking new Denti-Cal patients at 13 offices

Citing low reimbursement rates, Western Dental announced today that it will stop taking new patients with Denti-Cal coverage at 13 more of its California offices beginning June 1, 2015, and that it will close one office in San Francisco.

Read more Medical News

› Verified 4 days ago